Gene · 7517
Papers2,149
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,149
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel. | PLoS One | 2023 | 37656691 | PubTator, text mining | PubMed |
| Mapping the Genetic Interaction Network of PARP inhibitor Response. | bioRxiv | 2023 | 37645833 | PubTator, text mining | PubMed |
| An overview on the relationship between residential radon and lung cancer: what we know and future research. | Clin Transl Oncol | 2023 | 37610496 | PubTator, text mining | PubMed |
Development of a Microfluidic Flow Cytometer with a Uniform Optical Field (Uni-μFCM) Enabling Quantitative Analysis of Single-Cell Proteins and Its Applications in Leukemia Gating, Tumor Classification, and Hierarchy of Cancer Stem Cells. | ACS Sens | 2023 | 37602731 | PubTator, text mining | PubMed |
| Endothelial Cell Response in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children. | Int J Mol Sci | 2023 | 37569694 | PubTator, text mining | PubMed |
| Research progress on the role and mechanism of DNA damage repair in germ cell development. | Front Endocrinol (Lausanne) | 2023 | 37529603 | PubTator, text mining | PubMed |
| Association of RAD51, XRCC1, XRCC2, and XRCC3 Polymorphisms with Risk of Breast Cancer. | Genet Test Mol Biomarkers | 2023 | 37522793 | PubTator, text mining | PubMed |
| RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles. | Nat Commun | 2023 | 37488098 | PubTator, text mining | PubMed |
| Proliferating cell nuclear antigen inhibitors block distinct stages of herpes simplex virus infection. | PLoS Pathog | 2023 | 37486931 | PubTator, text mining | PubMed |
| Impact of DNA damage repair alterations on prostate cancer progression and metastasis. | Front Oncol | 2023 | 37434977 | PubTator, text mining | PubMed |
| Mapping genetic variants for nonsense-mediated mRNA decay regulation across human tissues. | Genome Biol | 2023 | 37434206 | PubTator, text mining | PubMed |
| PARP inhibitors: enhancing efficacy through rational combinations. | Br J Cancer | 2023 | 37430137 | PubTator, text mining | PubMed |
| Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications. | Cells | 2023 | 37408208 | PubTator, text mining | PubMed |
| Uncharacterized protein C17orf80 - a novel interactor of human mitochondrial nucleoids. | J Cell Sci | 2023 | 37401363 | PubTator, text mining | PubMed |
| Uncovering the Secrets of Prostate Cancer's Radiotherapy Resistance: Advances in Mechanism Research. | Biomedicines | 2023 | 37371723 | PubTator, text mining | PubMed |
| Individual Risk Assessment for Population Living on the Territories Long-Term Polluted by Organochlorine Pesticides. | Toxics | 2023 | 37368581 | PubTator, text mining | PubMed |
| Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. | Cancers (Basel) | 2023 | 37345145 | PubTator, text mining | PubMed |
| Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor. | Nature | 2023 | 37344587 | PubTator, text mining | PubMed |
| Ubiquitin-like protein 5 is a novel player in the UPR-PERK arm and ER stress-induced cell death. | J Biol Chem | 2023 | 37315790 | PubTator, text mining | PubMed |
| The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways. | Int J Mol Sci | 2023 | 37298600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7517/papers?page=6